Hear insights from key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing everything from navigating impending regulations, determining optimal pricing models, accelerating market access strategies and executing strategic, long term decisions to mitigate risk and build for success.

Join CBI’s 14th Biosimilars Summit and explore the current global climate for biosimilars, evaluate competition and benchmark with industry peers on how to navigate the changing regulations and landscape of the biosimilars market.